Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.
Journal of Animal Physiology and Animal Nutrition|March 24, 2016
Effects of dietary Tenebrio molitor meal inclusion in free-range chickensI Biasato, M De Marco, L Rotolo, et al.
Poultry Science|November 10, 2017
Yellow mealworm larvae (Tenebrio molitor) inclusion in diets for male broiler chickens: effects on growth performance, gut morphology, and histological findingsI Biasato, L Gasco, M De Marco, et al.
Animal : an International Journal of Animal Bioscience|July 25, 2024
Dehydrated and live black soldier fly larvae as environmental enrichment in indigenous slow-growing chickens: performance, gut health, and chitinolytic enzyme activityE Fiorilla, M Gariglio, F Gai, et al.
Scientific Reports|October 11, 2023
Stroke metrics during the first year of the COVID-19 pandemic, a tale of two comprehensive stroke centersLara Carvalho de Oliveira, Ana Ponciano, Nima Kashani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-OvestP F Conte, M Bruzzone, F Carnino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancerM Venturini, A Michelotti, L Del Mastro, et al.
Gynecologic Oncology|June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord OvestM Bruzzone, A Rubagotti, A Gadducci, et al.
Pageof 9